Prevalence of polypharmacy and associated factors among patients living with HIV infection in Spain: The POINT study

Morillo-Verdugo, Ramón; Sánchez-Rubio-Ferrández, Javier; Gimeno-Gracia, Mercedes; Robustillo-Cortés, María de las Aguas; Almeida-González, Carmen V.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 40(1): 1-7, Enero, 2022. graf, tab
Artículo en Inglés | IBECS (España) | ID: ibc-203285

Documentos relacionados

  1. Polifarmacia en paciente VIH mayor de 50 años
  2. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
  3. Infección concomitante por tuberculosis y el virus de la inmunodeficiencia humana: situación epidemiológica en el departamento del Meta, 2010-2015
  4. Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island.
  5. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain.
  6. Fatores associados à autoeficácia e à adesão da terapia antirretroviral em pessoas com hiv: teoria social cognitiva
  7. Características epidemiológicas y clínicas de una cohorte de pacientes con el virus de la inmunodeficiencia humana
  8. People living with HIV/AIDS: appraisal on dental care in Salta, Argentina
  9. Measuring Human Immunodeficiency Virus Reservoirs: Do We Need to Choose Between Quantity and Quality?
  10. Factores relacionados con la no adherencia a la terapia antirretroviral en pacientes con VIH/sida